Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mascarenhas

Showing results (81-90 of 3,365) with videos related to

Pageof 337
Sort By:
Ortodontia|May 1, 1977
[Frequency of malocclusion in school children of both sexes in the age group from 11 to 12 years old, residents of the Municipality of Palhoca (author's transl)]S C de Mascarenhas
Expert Review of Hematology|November 25, 2016
Should we be treating lower risk myelofibrosis patients with a JAK2 inhibitor?Guido Lancman, John Mascarenhas
Clinical Advances in Hematology & Oncology : H&O|August 27, 2019
Management of advanced phase myeloproliferative neoplasmsBridget Marcellino, John Mascarenhas
Irish Medical Journal|May 17, 2001
Haemorrhage from angiomyolipoma of kidney during pregnancy--a diagnostic dilemmaR Mascarenhas, P McLaughlin
Current Opinion in Obstetrics & Gynecology|June 9, 2001
Endometrial effects of etonogestrel (Implanon) contraceptive implantR Varma, L Mascarenhas
Expert Reviews in Molecular Medicine|February 28, 2004
Hereditary transthyretin amyloidosis: molecular basis and therapeutical strategiesMaria João Mascarenhas Saraiva
Expert Review of Hematology|July 13, 2018
Pacritinib to treat myelofibrosis patients with thrombocytopeniaDouglas Tremblay, John Mascarenhas
Journal of Pediatric Hematology/Oncology|November 27, 2013
Successful treatment of recurrent metastatic nasopharyngeal carcinoma with oxaliplatin and doxorubicinRajkumar Venkatramani, Leo Mascarenhas
Gastroenterology & Hepatology|June 25, 2010
Recent advances in liver transplantation for the practicing gastroenterologistRanjan Mascarenhas, Ahmet Gurakar
Journal of Hematology & Oncology|December 3, 2020
Novel therapeutics in myeloproliferative neoplasmsSangeetha Venugopal, John Mascarenhas
Pageof 337

Showing results (81-90 of 3,365) with videos related to

Sort By:
Pageof 337
Ortodontia|May 1, 1977
[Frequency of malocclusion in school children of both sexes in the age group from 11 to 12 years old, residents of the Municipality of Palhoca (author's transl)]S C de Mascarenhas
Expert Review of Hematology|November 25, 2016
Should we be treating lower risk myelofibrosis patients with a JAK2 inhibitor?Guido Lancman, John Mascarenhas
Clinical Advances in Hematology & Oncology : H&O|August 27, 2019
Management of advanced phase myeloproliferative neoplasmsBridget Marcellino, John Mascarenhas
Irish Medical Journal|May 17, 2001
Haemorrhage from angiomyolipoma of kidney during pregnancy--a diagnostic dilemmaR Mascarenhas, P McLaughlin
Current Opinion in Obstetrics & Gynecology|June 9, 2001
Endometrial effects of etonogestrel (Implanon) contraceptive implantR Varma, L Mascarenhas
Expert Reviews in Molecular Medicine|February 28, 2004
Hereditary transthyretin amyloidosis: molecular basis and therapeutical strategiesMaria João Mascarenhas Saraiva
Expert Review of Hematology|July 13, 2018
Pacritinib to treat myelofibrosis patients with thrombocytopeniaDouglas Tremblay, John Mascarenhas
Journal of Pediatric Hematology/Oncology|November 27, 2013
Successful treatment of recurrent metastatic nasopharyngeal carcinoma with oxaliplatin and doxorubicinRajkumar Venkatramani, Leo Mascarenhas
Gastroenterology & Hepatology|June 25, 2010
Recent advances in liver transplantation for the practicing gastroenterologistRanjan Mascarenhas, Ahmet Gurakar
Journal of Hematology & Oncology|December 3, 2020
Novel therapeutics in myeloproliferative neoplasmsSangeetha Venugopal, John Mascarenhas
Pageof 337